Coronavirus and The CCTS
How Coronvavirus (COVID-19) is impacting the CCTS
At The Ohio State University, the CCTS and The Ohio State University Wexner Medical Center, we’re continually monitoring and updating our response to the COVID-19 virus. We continue to align our recommendations with and follow guidelines from the Centers for Disease Control and Prevention, the World Health Organization and other city, state and federal agencies.
In our efforts to be proactive and maintain the health and safety of our faculty, staff and the community, staff at the CCTS will begin working remotely starting March 16th.
You can find contact information for CCTS staff here.
Impacts of COVID-19 on Research:
Stay up to date on the latest Ohio State news about the coronavirus (COVID-19) here: https://research.osu.edu/news-events/coronavirus-and-your-research-program/
https://keepresearching.osu.edu
FAQ on Sponsored Programs during COVID-19 crisis
What can I charge to grants during the COVID-19 crisis?
Sponsor Guidance on Expenditure Flexibilities during the COVID-19 crisis
NIH Guidance:
COVID-19 Resources for Applicants and Recipients of NIH Funding
Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19
Special OLAW Webinar on March 19: Pandemic Contingency Planning and Its Impact on Animal Care
Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need
NCATS is interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA Program-supported resources (e.g., advanced scientific instruments, highly-specialized facilities and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics and vaccines. For more information about this notice and the submission process, visit https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html.
Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
NCATS is interested in projects that repurpose existing drugs or therapeutics that already have begun or completed a Phase I clinical trial. By building upon previous research and development efforts, new uses for existing drugs or therapeutics can be advanced to testing in clinical trials more quickly than starting from scratch. For more information about this notice and the submission process, visit https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-012.html.
NIH continues to publish guidance updates, including a new Notice that addresses late applications. Please see:
- Extramural Nexus: Responding to Frequent Questions on Flexibilities Related to NIH Funding and COVID-19: Article directly below
- NOTICE: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-091.html
- NIH Office of Extramural Research Info & Video: https://nexus.od.nih.gov/all/2020/03/26/responding-to-frequent-questions-on-flexibilities-related-to-nih-funding-and-covid-19/
- NIH COVID Grant Info: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm
NIH Funding and COVID:
Responding to Frequent Questions on Flexibilities Related to NIH Funding and COVID-19
Posted on March 26, 2020 by Mike Lauer
The public health emergency due to COVID-19 is causing difficulties in many aspects of our lives. My colleagues and I here at NIH are well aware of the challenges being felt in the research community as institutions are closing, people are being asked to practice social distancing, and resources and attention are justifiably focused on public health needs. We are listening to your concerns and are working quickly to develop answers to your many questions.
We recently updated our Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients website with a slew of additional FAQs, new funding opportunities, as well as the video message from me, below, where I address some of the most common questions.
Since yesterday’s recording of this video, in response to community concerns about their ability to submit applications in a timely manner, we have published a notice announcing that grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020. This notice applies to all relevant funding opportunity announcements, including those that indicate no late applications will be accepted. A cover letter providing a justification is not required. NIH will be extending the expiration date of most FOAs expiring between now and May 1. Be sure to read the notice carefully for details.
Things are moving quickly. Please continue to communicate with us. We are listening.
I encourage you to monitor our website frequently. To help you identify updated content, the page now includes a link to page update history so you can easily see what’s new.
Follow the CCTS on social media for the latest updates: